Related Experiment Video
Updated: Jun 22, 2026
10:33
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Anionic amino acid-derived cationic lipid for siRNA delivery
Min Sung Suh1, Gayong Shim, Han Young Lee
1School of Life Sciences and Biotechnology, Korea University, Anam-dong, Seungbuk-gu, Seoul, South Korea.
Summary
A novel cationic lipid, N,N''-dioleylglutamide (DG), forms liposomes that effectively deliver small interfering RNA (siRNA) into cancer cells. DG-based liposomes demonstrate superior safety and efficacy compared to commercial alternatives for siRNA delivery in vitro and in vivo.
Area of Science:
- Biochemistry
- Nanotechnology
- Molecular Biology
Background:
- Effective delivery of small interfering RNA (siRNA) therapeutics is crucial for their clinical success.
- Current siRNA delivery systems face challenges related to safety and efficiency.
- Development of novel cationic lipids for liposomal siRNA delivery is an active area of research.
Purpose of the Study:
- To synthesize and characterize a new cationic lipid, N,N''-dioleylglutamide (DG).
- To evaluate the potential of DG-based liposomes as a safe and effective siRNA delivery system.
- To compare the performance of DG-based liposomes with existing commercial delivery agents.
Main Methods:
- Synthesis of the DG cationic lipid from oleylamine and glutamic acid.
- Formation of DG-based liposomes and complexation with siRNA (gel retardation assays).
- In vitro cell viability assays using A549, HeLa, and WM266.4 cell lines.
- Assessment of siRNA delivery efficiency using fluorescently labeled siRNA and specific gene silencing (survivin, RFP).
- In vivo evaluation of siRNA delivery in RFP-expressing tumor tissues in mice.
Main Results:
- DG-based liposomes effectively complexed with siRNA at an N/P ratio of 1.8.
- DG-based liposomes exhibited significantly higher cell viability compared to Lipofectamine 2000 and DC-Chol liposomes.
- Efficient delivery of fluorescent siRNA into cancer cell lines was observed, with higher intensity than Lipofectamine 2000.
- DG-based liposomes achieved greater reduction in survivin mRNA levels and red fluorescent protein (RFP) expression compared to controls.
- Intratumoral injection of DG-based liposome-siRNA complexes reduced tumor fluorescence in vivo.
Conclusions:
- N,N''-dioleylglutamide (DG) is a promising new cationic lipid for siRNA delivery.
- DG-based liposomes offer a safer and more effective alternative for both cellular and local in vivo siRNA delivery.
- These findings support the potential clinical utility of DG-based liposomes in RNA interference-based therapies.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...